Clinical significance of beta1-selectivity and intrinsic sympathomimetic activity in a beta-adrenergic blocking drug
- 1 May 1987
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 59 (13) , F33-F37
- https://doi.org/10.1016/0002-9149(87)90039-7
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Pindolol: A New β-Adrenoceptor Antagonist with Partial Agonist ActivityNew England Journal of Medicine, 1983
- Antihypertensive effects of pindololAmerican Heart Journal, 1982
- Treatment of angina pectoris with pindolol: The significance of intrinsic sympathomimetic activity of beta blockersAmerican Heart Journal, 1982
- Atenolol and Timolol, Two New Systemic β-Adrenoceptor AntagonistsNew England Journal of Medicine, 1982
- Intravenous Beta-Blockade in Coronary Heart DiseaseNew England Journal of Medicine, 1982
- β-Adrenoceptor Antagonists: New Drugs and New IndicationsNew England Journal of Medicine, 1981
- MetoprololNew England Journal of Medicine, 1979
- Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a β-adrenoreceptor blockerAmerican Heart Journal, 1979
- Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 2. Physiologic and metabolic effectsAmerican Heart Journal, 1979
- Comparison of propranolol, metoprolol, and acebutolol on insulin-induced hypoglycaemia.BMJ, 1976